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Advances in the isolation and gene expression profiling of single hematopoietic stem cells (HSCs) have permitted in-depth resolution of
their molecular program. However, long-termHSCs can only be isolated to near purity from adult mouse bonemarrow, thereby preclud-
ing studies of their molecular program in different physiological states. Here, we describe a powerful 7-day HSC hibernation culture sys-
tem that maintains HSCs as single cells in the absence of a physical niche. Single hibernating HSCs retain full functional potential
comparedwith freshly isolatedHSCswith respect to colony-forming capacity and transplantation into primary and secondary recipients.
Comparison of hibernating HSCmolecular profiles to their freshly isolated counterparts showed a striking degree ofmolecular similarity,
further resolving the coremolecular machinery of HSC self-renewal while also identifying key factors that are potentially dispensable for
HSC function, including members of the AP1 complex (Jun, Fos, and Ncor2), Sult1a1 and Cish. Finally, we provide evidence that hiber-
nating mouse HSCs can be transduced without compromising their self-renewal activity and demonstrate the applicability of hiberna-
tion cultures to human HSCs.
INTRODUCTION
The blood-forming system is sustained by a rare subset of
hematopoietic stem cells (HSCs) with the potential to
differentiate into all mature blood cell types and to create
equally potent daughter HSCs to maintain tissue homeo-
stasis (Doulatov et al., 2012; Eaves, 2015; Ganuza et al.,
2020; Laurenti and Göttgens, 2018). As the seed cells for
the blood system, their clinical potential for cellular thera-
pies is vast and the need to understand their molecular pro-
gram in different physiological states is critical for their
therapeutic application. Recently, cell culture conditions
have been reported to produce large numbers of functional
mouse and human HSCs (hHSCs) (Fares et al., 2017; Wil-
kinson et al., 2019) but, in all cases, the substantial major-
ity of cells produced are non-HSCs (Bak et al., 2018;Gundry
et al., 2016; Shepherd and Kent, 2019; Wagenblast et al.,
2019).
In the absence of robust purification strategies for func-
tional HSCs in culture, it becomes virtually impossible to
study the molecular profile of HSCs removed from their
in vivo microenvironment. Previous studies have
highlighted the potential for retaining long-term HSC
(LT-HSC) function in cultures with low amounts of prolifer-
ation in the absence of excessive cytokine-induced
signaling (Kobayashi et al., 2019; Yamazaki et al, 2006,
2009), although these cultures were still predominantly
non-HSCs. An in vitro system that could retain highly puri-
fied single HSCs would offer the potential to molecularly
profile niche-independent HSCs and to resolve the essen-
tial components of self-renewal in vitro.
Here, we describe such a system, demonstrating that fully
functional mouse LT-HSCs can be maintained in minimal
cytokine conditions over a period of 7 days without under-
going cell division. This novel cell culture system preserves
the core features of HSCs, including the speed of quies-
cence exit, subsequent cell-cycle kinetics, mature cell
production, and HSC self-renewal activity in serial trans-
plantation assays. The functional properties of these hiber-
nating HSCs are virtually indistinguishable from freshly
isolated HSCs and molecular profiling by single-cell RNA
sequencing (scRNA-seq) shows a high degree of overlap
with freshly isolated HSCs, but also reveals a number of
molecular changes that identify genes potentially dispens-
able for retaining HSC function.
RESULTS
Single LT-HSCs can retain multipotency in vitro under
minimal cytokine stimulation
Previous studies suggested that stem cell factor (SCF) and
thrombopoietin (TPO) are essential for HSC self-renewal
and proliferation, but potentially dispensable for stem
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cell maintenance (Yamazaki et al., 2006, 2009; De Graaf
and Metcalf, 2011). A number of studies use gp130 family
members (e.g., interleukin-11 [IL-11], IL-6) in HSC mainte-
nance conditions, including our own studies which typi-
cally use 20 ng/mL of IL-11 alongside 300 ng/mL of SCF
(Kent et al., 2008b; Kent et al., 2013; Shepherd et al.,
2018). To test the absence of SCF and TPO, we cultured sin-
gle mouse bone marrow CD45+EPCR+CD48CD150+Sca1-
high LT-HSCs, which are 60% functional HSCs by single-
cell transplantation (Wilson et al., 2015), in the presence
of 20 ng/mL IL-11 alone in both serum-containing (Kent
et al., 2013; Shepherd et al., 2018) and serum-free condi-
tions (Wilkinson et al., 2019) (Figure 1A). Between 20%
and 40% of single LT-HSCs survived 7 days of culture (Fig-
ure 1B), making them considerably more resilient to cyto-
kine depletion than single sorted progenitor cell fractions
(LinSca1+c-Kit+), where no cells survived past 2 days
(data not shown). Interestingly, 99.2% (634 of 639 cells)
of the surviving input LT-HSCs were maintained as single
cells for the 7-day period (Figure 1C), and single-cell time-
lapse imaging and tracking confirmed that cells did not un-
dergo division followed by death of one daughter cell
(Video S1). Together this prompted us to term the minimal
cytokine condition as a ‘‘hibernation’’ condition, similar to
the cellular state of LT-HSCs described after the addition of
lipid raft inhibitors (Yamazaki et al., 2006).
To assess the functional potential of single LT-HSCs in
the hibernation condition (hibHSCs), 300 ng/mL SCF was
added to mirror cytokine combinations previously applied
to freshly isolated LT-HSCs (Kent et al., 2008a; Kent et al.,
2013; Shepherd et al., 2018). Time to first and second divi-
sion was indistinguishable from freshly isolated LT-HSCs
receiving SCF (Figure 1D), and clonal proliferation and sur-
vival over the subsequent 10 days was also similar, as indi-
cated by clone size distribution being nearly identical to
freshly isolated HSCs stimulated for 10 days (Figure 1E).
In accordance with this, single hibHSCs also retained their
multipotency in colony-forming cell (CFC) assays (Figures
1F and 1G) and 60%–70% of single cells generated at least
three different lineages (Figure 1H), as determined by flow
cytometry. Together, these data suggest that HSCs surviv-
ing cytokine depletion exist in a state of prolonged hiber-
nation and can be revived to function indistinguishably
from freshly isolated HSCs.
Hibernating HSCs are fully functional in
transplantation assays
To assess whether cells cultured in the absence of SCF or
TPO retained their HSC self-renewal expansion capability,
single day 7 hibHSCs were transplanted and their repopu-
lation capacity was compared with freshly isolated HSCs
(Figure 2A); 62.5% (15/24) and 45.8% (13/29) of primary
Figure 1. Absence of SCF and TPO maintains HSCs as single multi-potent cells in vitro
(A) Single CD45+EPCR+CD48CD150+Sca1high LT-HSCs were sorted into individual wells and cultured in the presence of IL-11, in serum-
supplemented or serum-free medium and in the presence or absence of SCF. For SCF-supplemented cultures (green plate), daily cell counts
were performed for 10 days. For cultures only containing IL-11 (red plate), HSCs were supplied with SCF on day 7 post-isolation after which
daily cell counts were performed for an additional 10 days. In all cases, clone size was assessed at day 10 post-SCF addition.
(B) HSC survival is decreased in the absence of SCF compared with SCF-supplemented medium (+serum/+SCF n = 355, 5 biological
replicates; +serum/SCF n = 1,722, 7 independent experiments; serum/+SCF, N = 144, 2 independent experiments, serum/SCF n =
284, 3 independent experiments).
(C) Numbers of wells with >2 cells were scored to determine the number of clones that had divided. At day 7 post-isolation, only culture
conditions without SCF maintained HSCs as single cells.
(D) Cell division kinetics post-SCF addition. Entry into cell cycle was comparable between freshly isolated HSCs (green solid line) and cells
that had been maintained as single cells for 7 days (orange solid line) in serum-supplemented media. Time to subsequent cell division
(dotted lines) was not significantly different between conditions (SCF added at day 0, n = 355, 5 independent experiments; SCF added at
day 7, n = 1,722, 7 independent experiments).
(E) Colony size was measured on day 10 post-SCF addition and no difference in clone size distribution was observed between HSCs cultured
in the presence of SCF from day 0 and post-hibernation HSCs (day 7 + 10).
(F) Single LT-HSCs were cultured for 7 days in IL-11 alone, in serum-supplemented or serum-free medium. After 7 days, single hibernating
LT-HSCs were individually transferred into a cytokine-rich methylcellulose CFC assay and cultured for an additional 14 days. On day 14,
lineage composition of individual colonies was assessed by flow cytometry.
(G) Colony-forming efficiency for freshly isolated single LT-HSCs, single LT-HSCs cultured in serum-supplemented and serum-free hiber-
nating cultures (fresh, n = 300, 3 biological replicates; serum-free, n = 121, 5 independent experiments; +serum, n = 230, 6 independent
experiments).
(H) Colony subtype analysis showed that the majority of single cells (~80%) generated colonies of at least three lineages in colony-forming
unit (CFU) assays (hibHSC serum-free, n = 70, 4 independent experiments; hibHSC + serum, n = 166, 3 independent experiments). Colonies
were defined as MK (containing cells positive for megakaryocyte marker CD41), GM (containing cells positive for granulocyte/monocyte
markers Gr1 and CD11b), GEM (positive for GM and erythrocyte markers Gr1, CD11b, and Ter-119), GMM (positive for GM and MK markers),
and GEMM (positive for GM, MK, and E markers), as described in the Experimental procedures. Bars show mean with SEM. Unpaired t test:
*p < 0.05, **p < 0.01, ***p < 0.001.
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recipients transplanted with single hibHSCs (without
serum and with serum, respectively) had >1% multi-line-
age donor chimerism at 16–24 weeks post-transplantation
compared with 48.8% (33/69) of freshly isolated HSCs (Fig-
ure 2B). Secondary transplantation efficiency was also high
(Figure 2C), suggesting that the period of 7 days in vitro had
no impact on HSC self-renewal. This was further supported
by the observation of no significant differences in mature
cell production between hibHSCs and freshly isolated
HSCs, as determined by the relative proportions of the
HSC subtype produced in single-cell transplantation exper-
iments (Figure 2D). Notably, despite these high functional
purities, the total yield of functional HSCs was slightly
lower considering that some HSCs do not survive hiberna-
tion. These data provide formal evidence that, following
7 days of SCF and TPO depletion and in the complete
absence of a supportive stem cell niche, LT-HSCs can
retain full functional potential as assessed by serial
transplantation.
High CD150 expression prospectively enriches for
resilient HSCs
Since only a proportion of phenotypic LT-HSCs survive hi-
bernation conditions, we used flow cytometric index-sort
data to determine whether levels of specific cell surface
markers might associate with survival. Expression levels
of the SCF receptor (c-Kit) did not select for surviving
HSCs, while higher CD45 and EPCR expression were
modestly increased on hibHSCs compared with cells that
did not survive hibernation conditions (data not shown).
High CD150 expression strongly associated with higher
survival at day 7 (Figure 3A). To verify whether CD150
could be used to prospectively enrich for resilient HSCs,
single LT-HSCs were sorted as CD150mid or CD150high
A
7 days























































































































(defined by lineage bias):
Figure 2. Hibernating HSCs maintain
in vivo functional activity
(A) HSCs were cultured in hibernation con-
ditions in either serum-supplemented or
serum-free medium. Single fresh or day 7
hibernating LT-HSCs were transplanted into
W41-CD45.1 recipients (fresh n = 69; serum-
free n = 24; +serum n = 29). Secondary
transplantations were undertaken in all mice
with donor engraftment (>1%) at 16–
24 weeks post-transplantation.
(B and C) Graphs show percent donor
chimerism in the peripheral blood of primary
(B) and secondary (C) recipient mice at 16–
24 weeks post-transplantation. Recipients
with chimerism >1% and at least 0.5% of GM,
B, and T cells were considered to be repopu-
lated. (Triangles represent mice where
chimerism reached >1% at weeks 20–24 post-
transplantation but had not done so by
16 weeks.)
(D) No significant difference was observed in
the balance of mature cell outputs between
freshly isolated and post-hibernation HSCs.
Based on donor myeloid (M) to lymphoid (L)
ratio at 16 weeks in primary recipients, the
founder HSC was retrospectively assigned one
of the following subtypes: a (alpha, M:L > 2),
b (beta, M:L > 0.25 < 2), g (gamma, M:L <
0.25), d (delta, M:L < 0.25 and failure to
contribute to myeloid lineage past 16 weeks)
in accordance with Dykstra et al. (2007) (HSC
n = 31/69; hibHSC (+serum) n = 12/29;
hibHSC (serum-free) n = 15/24).
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and cultured in hibernation conditions. CD150high HSCs
show significantly higher (4.2-fold) survival on day 7
compared with CD150mid HSCs, confirming that CD150
expression can enrich for phenotypic LT-HSCs that could
survive hibernation conditions (Figure 3B). We next as-
sessed whether CD150 levels on surviving LT-HSCs associ-
ated with successful transplantation and found no signifi-




Figure 3. Higher expression of CD150 identifies resilient LT-HSCs
(A) Flow cytometric index-sort data were used to determine the CD150 expression level of LT-HSCs at the time of isolation. Cells that did
not survive at day 1 and day 7 were compared with those that survived out to day 7, with the latter population of cells correlating with
higher CD150 expression. A boxplot shows the median with interquartile range. Vertical lines represent outermost quartiles. Black dots, if
present, are extreme outliers. Unpaired t test: *p < 0.05, **p < 0.01, ***p < 0.001.
(B) Prospectively sorted CD150high LT-HSCs show 4.2-fold higher survival than CD150mid LT-HSCs (n = 480, 5 independent experiments).
Paired two-tailed t test.
(C) Hibernating HSCs in serum-free and serum-supplemented conditions were transplanted, and their CD150 levels retrospectively as-
sessed. Cells able to repopulate a recipient (black) did not differ in initial CD150 expression levels compared with cells unable to repopulate
(gray).
(D) HSCs with high or low expression of CD150 were determined using index-sorting data from freshly isolated HSCs that were cultured for
7 days in serum-free medium supplemented with 20 ng/mL IL-11 and 300 ng/mL SCF. Three biological replicates were analyzed, and in each
case the top third and bottom third of CD150 expressers were analyzed as CD150high and CD150low, respectively. Daily cell counts were
performed to assess cell division kinetics. Entry into cell cycle and the second division were not significantly altered between CD150high
and CD150low LT-HSCs.
(E) Using the same experimental data from Figure 3D, colony sizes from single LT-HSCs were measured on day 10 and clone sizes from single
LT-HSCs with high expression of CD150 were significantly reduced compared with those with low CD150 expression (bars show mean with
SD. Sidak’s multiple comparison test: **p < 0.01).
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successfully repopulated recipients versus those that did
not (Figure 3C). Interestingly, when we compared the cell
division kinetics and 10-day colony size of single HSCs
with high versus low expression of CD150, we observed
smaller colonies from cells expressing high levels of
CD150 (Figures 3D and 3E). Together these data suggest
that, while higher CD150 expression can isolate cells en-
riched for resilient LT-HSCswith lower in vitro proliferation,
the cells with lower CD150 expression that survive do not
have compromised transplantation ability, which is sup-
ported by previous datasets examining CD150 expression
in freshly isolated and transplanted HSCs (Beerman et al.,
2010; Morita et al., 2010; Wilson et al., 2015).
Hibernating LT-HSCs can be transduced without
undergoing division
To further explore the experimental and clinical potential
of hibHSC culture conditions, we next assessed whether
transgenes could be delivered during the hibernation
period. Small bulk populations of LT-HSCs were isolated
and exposed to a GFP-containing lentivirus for 2 days
and then re-sorted into single-cell cultures to determine
single-cell transduction efficiencies and survival (Fig-
ure 4A). After 10 days, 40% of the original sorted clones
(284/657) successfully produced colonies, with 17.6%
(50/284) of the surviving clones being GFP+ (Figure 4B).
In a second experiment to assess the in vivo functional po-
tential of transduced hibernating LT-HSCs, bulk cells were
transplanted following the 2-day transduction and as-
sessed for GFP+ donor cell repopulation at 4, 8, and
16 weeks post-transplantation (Figure 4A). All recipient
mice were positive with initial reconstitution levels
ranging from 2% to 6% GFP+ cells (Figures 4C and 4D),
and this contribution was stable throughout the moni-
toring period, although early time points appear slightly
higher, suggesting that HSCs with less-durable self-renewal
might be preferentially transduced. Together, these data
demonstrate that lentiviral constructs can be successfully
delivered to LT-HSCs in hibernation cultures without cell
division.
Hibernating LT-HSCs share a core gene expression
program with freshly isolated LT-HSCs
LT-HSCs deprived of SCF and TPO in hibernation condi-
tions retain their functional properties, including the abil-
ity to reconstitute primary and secondary recipients (Fig-
ures 2B and 2C). Aside from IL-11, these LT-HSCs were
cultured without signals from the hematopoietic niche or
neighboring cells, making the transcriptome of these LT-
HSCs a useful comparator for determining which genes
might be dispensable for LT-HSC function. To address this
question, we performed scRNA-seq on LT-HSCs cultured
in serum-free hibernating conditions for 7 days (n = 106)
and compared them to freshly isolated single LT-HSCs
(n = 165) and also to LT-HSCs stimulated with SCF for
16 h (from both HSC + SCF [n = 63] and hibHSC + SCF
[n = 127]) to determine the common pathways of activa-
tion upon SCF stimulation.
To determine broad differences between cell fractions, we
performed dimensionality reduction using Uniform Mani-
fold Approximation and Projection (UMAP) on single cells
from all four conditions. Cells from each physiological
setting clustered together in a unique space (Figures 5A
and S1A). These data indicate that, while there is substan-
tial similarity to the molecular profile of freshly isolated














































































Figure 4. Single hibernating HSCs can be
manipulated by lentiviral transduction
(A) CD45+EPCR+CD48CD150+ (ESLAM) cells
were isolated and transduced with ZsGreen
lentivirus and cultured together for 2 days in
StemSpan supplemented with 10% fetal calf
serum and IL-11. Cells were collected and
virus was removed by collecting and re-
sorting the cells into single wells and
cultured in SCF-supplemented media for
additional 10 days. A total of 4,001 total
viable cells (a mixture of transduced and
non-transduced cells) were re-sorted and
transplanted into W41-CD45.1 (n = 6 re-
cipients), and donor contribution and GFP
expression were assessed by serial bleeds and
flow cytometry analysis.
(B) Graph shows the percentage of clones surviving after 10 days post-addition of SCF, and the green bar indicated the percentage of GFP+
clones.
(C and D) Chimerism levels (20%–40%) were stable across all recipients at all time points (C), and an average of 1%–2% of donor cells was
positive for GFP at 16 weeks post-transplantation (D). Bars show mean with SEM.
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being removed from the in vivo microenvironment for
7 days.
To assess the similarity of hibHSCs to freshly isolated
HSCs further, we compared the expression levels of key
HSC regulators that comprise the previously reported Mo-
lecular Overlap (MolO) gene signature (Wilson et al.,
2015). Overlaying MolO scores on the UMAP plot shows
that the highest MolO scores are present in the freshly iso-
lated HSCs, followed by the hibHSCs, and then their SCF-
stimulated counterparts (Figure 5B). This pattern is
mirrored in the violin plots displaying individual single-
cellMolO scores by physiological condition (Figure 5C). In-
dividual genes comprising the MolO score and their rela-
tive expression across the four biological states are provided
in Figure S1B. The relatively high MolO scores in hibHSCs
indicates the utility of the MolO score for identifying func-
tional HSCs irrespective of their physiological state. The
similarity in these molecular features also suggests that
other factors must be contributing to the clear separation
between freshly isolated HSCs and hibHSCs.
Another example of molecular similarity between































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































Figure 5. Gene expression profiling re-
veals a common transcriptional program
between freshly isolated and hibernating
HSCs
(A) Uniform Manifold Approximation and
Projection (UMAP) of scRNA-seq profiles
derived from four distinct populations (HSC,
blue dots; hibHSC, red dots; HSC + SCF, green
dots; hibHSC + SCF, orange dots).
(B) The HSC-specific Molecular Overlap
(MolO) gene signature score was computed
based on average expression of signature
genes and projected onto the UMAP distri-
bution.
(C) MolO scores for the individual HSCs in
each physiological state with the HSCs and
hibHSCs having the highest overall scores.
(D) Cell-cycle scores were computed for each
cell and identified states were projected on
the UMAP display from 5A (G1(G0), pink; G2/
M, orange; S, blue).
(E) A proportional representation of cell-cy-
cle stages of all cells within each distinct
population (G1(G0), pink; G2/M, orange; S,
blue).
(F) Heatmap of previously identified HSC-
specific proliferation signature genes (Ven-
ezia et al., 2004) sorted by cell type with low
expression in HSCs and hibHSCs and high
expression in both sets of SCF-stimulated
cells.
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components of the cell-cycle machinery were assessed to
predict the cell-cycle stage of each profiled LT-HSC (Nestor-
owa et al., 2016; Hamey andGöttgens, 2019). Again, UMAP
clustering (Figure 5D) shows that cell-cycle status is not the
primary driver of molecular differences between freshly
isolated and hibHSCs, with the vast majority of cells in
both cases being in the G0/G1 phase of the cell cycle (Fig-
ure S1C). Overall, more than 80% of freshly isolated
HSCs and hibHSCs had molecular profiles consistent with
being in the G0/G1 phase of the cell cycle (Figure 5E),
whereas both SCF-stimulated HSC fractions had fewer
than 40% G0/G1 cells. These data also accord with the
cell-cycle kinetics observed in Figure 1D, where cells that
divide early in the curve (i.e., between 20 and 30 h after
stimulation) would be expected to have progressed to the
S or G2 phase by 16 h after stimulation. This is further
emphasized by the heatmap in Figure 5E which displays
the HSC proliferation gene signature from Venezia et al.
(2004), where both freshly isolated and hibHSCs express
low levels of proliferation-related genes (Figures 5F and
S2A–S2E). Finally, we also assessed markers of autophagy
and senescence and in neither case did we observe a signif-
icant enrichment (Figures S3A and S3B).
Hibernation cultures resolve common pathways of
cytokine activation
Historically, the molecular impact of adding specific cyto-
kines to HSCs has been performed following their direct
isolation from the in vivo microenvironment. However,
the impact that membrane dynamics, protein turnover,
and transcriptional priming would have on the response
of an HSC to a particular extracellular signal remains un-
clear. Hibernation cultures offer a different physiological
state of highly purified HSCs from which to understand
the direct impact of cytokine addition to a functional
HSC. First, we observed the impact of culturing HSCs in
IL-11 alone during the hibernation condition, allowing
us to resolve the pathways activated or suppressed in
response to IL-11 (Figures S3C–S3E). Next, using SCF as a
stimulant, we profiled freshly isolated HSCs and hibHSCs
to identify individual gene expression patterns associated
with SCF stimulation (HSC + SCF, hibHSC + SCF). We first
generated differentially expressed gene lists from the HSC
versus HSC + SCF and hibHSC versus hibHSC + SCF (Fig-
ure 6A). Twenty-seven genes were commonly differentially
expressed (13 up and 14 down) upon addition of SCF with
an expected activation of ATP generation and nucleotide
metabolism alongside a number of positive cell-cyclemedi-
ators (Mcm2, Mcm4, Mcm10, Rad51, and Rad51ap1) and a
reduction in developmental andMAPK-mediated signaling
(Figures 6B and S4A). In addition to these expected
changes, we also identified SCF targets specifically induced
inHSCs (Figure S4A) and show that expression ofMif (Ohta
et al., 2012) (an inflammatory cytokine promoting survival
and proliferation) and Txn1 (Schenk et al., 1994) (regulator
of AP-1 signaling) are directly promoted upon SCF addition
to functional HSCs.
Hibernating HSCs downregulate the AP1 complex and
other stem cell regulators
Despite the strong overlap in cell-cycle and MolO gene
signature expression, hibHSCs form a distinct cluster
away from freshly isolated HSCs (Figures 5A and Fig-
ure S4B). While some of this distance could be attributable
to downregulation of specific MolO genes (including
Sult1a1 and Gimap1, Figure 6D), global differential gene
expression analysis between HSCs and hibHSCs identified
116 upregulated and 138 downregulated genes (Figure 6C).
Among those additional genes whose expression was
significantly reduced, a number of AP-1 complex members
were identified, including Jun and Fos and their co-regu-
lator Ncor2 as well as molecules with previously described
Figure 6. Hibernating HSCs have a unique molecular profile of stress response
(A) Differential gene expression (DGE) was computed for two separate comparisons: (1) comparison of fresh HSCs (HSC) against SCF-
stimulated HSCs (HSC + SCF); (2) comparison of hibernating HSC (hibHSCs) against hibHSCs post-SCF-stimulation (hibHSC + SCF) (negative
binomial distribution, adjusted with Benjamini-Hochberg correction). Venn diagrams represent the number of genes commonly enriched
in unstimulated populations (HSC and hibHSC) and SCF-stimulated populations (HSC + SCF and hibHSC + SCF) from both separate DGE
computations.
(B) Gene ontology term enrichment was computed based on differentially expressed genes, as outlined in (A). Minimum p value > 0.05 to
be considered significantly enriched.
(C) Volcano plot of differentially expressed genes (red dots), comparing fresh HSCs (HSC) and hibernating HSCs (hibHSC) (negative
binomial distribution, adjusted with Benjamini-Hochberg correction).
(D) Dot plot representing the average normalized expression of genes across the four distinct populations. Genes of interest and MolO
signature genes were selected from DGE in (C). The size of each dot indicates the proportion of cells with normalized expression level >0
(scaled expression represented by color intensity).
(E) KEGG pathway enrichment in unstimulated hibernating HSCs (hibHSC), showing selected metabolic and signal transduction pathways
(enrichment cutoff: adjusted p value > 0.05).
(F) Violin plots of normalized gene expression of selected differentially expressed genes, enriched in unstimulated hibernating HSCs
(hibHSCs).




Figure 7. Hibernation conditions keep the majority of human HSCs as single cells
(A) Single human HSCs (CD34+CD38CD90+CD45RACD19CD49f+) from umbilical cord blood were sorted into individual wells and cultured
in the presence of IL-11 with or without SCF. In parallel, human HSCs were bulk-cultured for 7 days in the absence of SCF and transplanted
at three different cell doses (22, 110, and 218) into immunodeficient recipients and monitored for engraftment.
(B) Survival of HSCs in the presence or absence of SCF over 7 days, where absence results in 1.5-fold reduced survival compared with SCF-
supplemented cultures (fresh n = 192; post-hibernation, n = 672; 5 independent experiments)
(C) The proportion of cells divided at 5–7 days in culture with and without the addition of SCF is displayed. Significantly more cells divide in
the presence of SCF with the majority of cells in hibernation conditions remaining as single cells (fresh, three independent experiments,
post-hibernation, five independent experiments). Bars show mean with SEM.
(D) The graphs show the percentage of human cell engraftment (%CD45++) in PB from transplanted mice at 12 and 20 weeks post-
transplantation (cell dose 22, n = 5; 110, n = 4; 218, n = 3). The threshold for events considered as positive was >0.01% with a minimum of
30 analyzed events. Non-engrafted mice shown below the dashed line. CD45++ indicates cells positive for two distinct CD45 antibodies.
Bars show mean with SEM.
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roles in HSC biology, such as Cish (Schepers et al., 2012)
and Vwf (Figures 6D and S4C). Since hibHSCs retain their
functional properties in vivo, these data suggest that high
levels of these genes are not a requirement for HSC func-
tion. On the other hand, pathways that were highly upre-
gulated in hibHSCs were associated with stress response
and nutrient deprivation, consistent with being kept in
minimal cytokine conditions, and KEGG pathway analysis
identified cAMP and mTOR signaling (Dhawan and Lax-
man, 2015) alongside glycolysis and fatty acid biosynthesis
(Figure 6E). This accords with enrichment of HSC pro-sur-
vival genes Ier3 and Pdcd1lg2 expression in hibernating
HSCs. Of additional interest, multiple HLF target genes,
including Lyz1 and Lrrc8a, were overexpressed in hibernat-
ed HSCs, potentially supporting the notion that HSCs are
exerting a stress response to maintain survival/quiescence
(Komorowska et al., 2017) in response to cytokine depriva-
tion (Figures 6F and S5).
Human HSCs can be retained as single cells in
hibernation conditions
To investigate whether cytokine deprivation had a similar
effect on human HSCs (hHSCs), we isolated single human
CD34+CD38CD90+CD45RACD19CD49f+ cells from
cord blood and cultured them in serum-free medium
with human IL-11 alone for 7 days (Figure 7A). Similar to
mouse LT-HSCs, survival was lower with cytokine depriva-
tion (Figure 7B) and, although some cells divided (25.6%,
Figure 7C), a large proportion remained as single cells
compared with hHSCs under standard cytokine conditions
(Belluschi et al., 2018; Ortmann et al., 2015). The fact that
some hHSCs divided may be due to the starting purity or
activation state of HSCs from cord blood. Upon transplan-
tation of limited numbers of day 7 cultured hHSCs, repopu-
lation was stable out to 20 weeks post-transplantation, but
donor repopulation was below detection for the lowest-
dose recipients (Figure 7D). Together these results demon-
strate that IL-11 alone can maintain a proportion of
multi-potent hHSCs in a non-dividing state, but further
culture optimization would be required to support reten-
tion of large numbers of fully functional hHSCs.
DISCUSSION
Recent studies have produced a substantial amount of sin-
gle-cell gene expression data from normal and malignant
hematopoietic cells isolated from the mouse bone marrow
(Shepherd and Kent, 2019). As a result, the transcriptional
program of a quiescent ‘‘steady-state’’ LT-HSC is firmly es-
tablished. Which genes drive individual LT-HSC properties
(e.g., quiescence, self-renewal, differentiation, stress
response) is much less well understood, and is complicated
by only being able to obtain highly purified functional LT-
HSCs from a single physiological state (i.e., quiescent cells
from the bone marrow niche). Indeed, studies that have
compared LT-HSCs to their downstream progenitors have
identified ‘‘cell-cycle’’ changes as the dominant molecular
feature separating LT-HSCs from non-HSCs (Passegué
et al., 2005;Wilson et al., 2015). Hibernation cultures allow
us to isolate and maintain functional LT-HSCs for pro-
longed periods of time in the absence of other cells without
undergoing cell division or differentiation, thereby allow-
ing the resolution of the common molecular program of
HSCs in different physiological state. We identify mole-
cules potentially dispensable for HSC function and a com-
monmolecular program of SCF activation in purified HSCs
from distinct states. Finally, our study also resolves a debate
about the impact of serum exposure on the cell fate of LT-
HSCs (Domen and Weissman, 2000; Ieyasu et al., 2017;
Rogers et al., 2008), showing that LT-HSCs can be cultured
in the presence of serum for 7 days without undergoing dif-
ferentiation or proliferation.
Distinct endogenous signaling pathways have been
shown to regulate LT-HSC survival, self-renewal, and pro-
liferation in both mouse (Wohrer et al., 2014) and hu-
man (Knapp et al., 2017). A similar cellular phenomenon
of hibernation was observed when LT-HSCs were exposed
to inhibitors that blocked lipid raft clustering (even in
the presence of SCF) and remained undifferentiated as
single cells for 5–7 days in culture (Yamazaki et al.,
2006). Despite being deprived completely of TPO and
SCF signaling, our hibernation cultures contain IL-11,
without which all cells die within 48 h. One of the key
pathways activated by IL-11 is gp130, which has been
historically implicated in a wide array of stem cell sys-
tems, including mouse embryonic stem cells with LIF
(Nichols et al., 2001), the Drosophila germ stem cell niche
with Upd (Amoyel and Bach, 2012), mouse neural stem
cells with CTNF and LIF (Shimazaki et al., 2001), mouse
muscle stem cells with OSM (Sampath et al., 2018), and
mouse HSCs with IL-6 and IL-11 (Yoshida et al., 1996;
Audet et al., 2001). Of particular interest, OSM was
shown to promote muscle cell engraftment without
inducing proliferation (Sampath et al., 2018), lending
additional support to the hypothesis that gp130 stimu-
lants may regulate survival of quiescent stem cells in
multiple stem cell systems.
Whereas other in vitro conditions have been shown to
maintain mouse LT-HSCs, these systems uniformly create
populations of cells in which LT-HSCs are the vast minor-
ity of the final culture (Bak et al., 2018; Gundry et al.,
2016; Wagenblast et al., 2019; Wilkinson et al., 2019).
In the absence of a robust in vitro LT-HSC purification
strategy, molecular studies are therefore compromised by
large numbers of contaminating non-HSCs. Our study
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averts this issue by retaining functional LT-HSCs as single
cells. The gene expression programs of single functional
LT-HSCs in 7-day hibernation conditions show a high
retention of known self-renewal regulators, and are
consistent with the cells being in G0/G1. They also iden-
tify several regulators whose absence does not impact
HSC engraftment or serially repopulation. One such set
of factors was the AP1 complex, where expression of
several members including Jun, Fos, and Ncor2 was signif-
icantly reduced in hibernation cultures. This is potentially
due to the hibernation cultures driving their extinguished
expression and cells that do not have sufficient amounts
of AP1 complex members do not survive. In contrast, in
vivo loss or reduced AP1 function leads to increased prolif-
eration and differentiation (Santaguida et al., 2009). It
may be that expression of these molecules is rescued
upon transplantation when HSCs expand, although the
SCF-induced entry into cell cycle does not on its own
initiate their expression.
A previous study has reported that low cytokine concen-
tration in culture facilitates themaintenance of engraftable
mouse and hHSCs (Kobayashi et al., 2019) with reduced
proliferation in vitro and this finding is supported by studies
showing that slow-dividing LT-HSC clones were much
more likely to retain HSC function (Dykstra et al., 2006;
Laurenti et al., 2015). However, none of these studies
were able to retain single LT-HSCs at high purities with
indistinguishable properties from freshly isolated LT-
HSCs, making it impossible to perform molecular studies
on single functional HSCs or tomanipulate them at the sin-
gle-cell level. Hibernation cultures permit such analyses
since single LT-HSCs do not lose any functional capacity
with a highly similar, if not slightly improved, primary
and secondary transplantation capacity compared with
freshly isolated HSCs.
The finding that high CD150 expression levels prospec-
tively identify resilient HSCs that survive hibernation are
broadly consistent with data that implicate CD150 as a
marker of LT-HSCs withmore durable self-renewal capacity
in serial transplantation assays (Beerman et al., 2010; Kent
et al., 2009; Morita et al., 2010). The highest levels of
CD150 also associated with a delayed engraftment in pri-
mary transplantations, an initial deficiency in making
lymphoid cells (Kent et al., 2009; Morita et al., 2010), and
an ability to create daughter HSCs with full multi-lineage
potential (Dykstra et al., 2007; Komorowska et al., 2017).
This further accords with the increased number of a-HSCs
(myeloid-biased) observed in our transplantation data.
The delay in engraftment observed generally in a-HSCs
may be related to the dynamics of quiescence/activation
of daughter LT-HSCs in a transplantation scenario and
our in vitro hibernation system offers the chance to study
HSC activation in a distinct physiological context with un-
precedented resolution. This latter capacity is particularly
important in the context of HSC transplantation where
cells need to exit, and eventually return to, quiescence dur-
ing any sort of in vitro culture period and subsequent re-
seeding of recipient bone marrow.
Optimization of hibernation cultures for manipu-
lating highly purified LT-HSCs would also have a wide
range of applications in experimental and clinical
research. The knowledge that LT-HSCs are fully func-
tional during hibernation offers the opportunity to
manipulate them at the single-cell level with precise
assessment of the impact of specific modifications.
Our data show that genetic modification can be under-
taken in hibernation cultures which could potentially
set the stage for the delivery of multiple viral constructs
during the culture period. This would permit studies of
combinatorial genetic modifications in highly purified
LT-HSCs, as opposed to a heterogeneous pool of stem
and progenitor cells typically assayed in such protocols.
Finally, we provide proof-of-principle evidence that hi-
bernation cultures can be adapted to the human
setting, offering substantial potential for implementing
genetic modifications in hHSCs and setting the stage
for more precise interrogation of the functional proper-
ties of individual LT-HSCs.
EXPERIMENTAL PROCEDURES
Mice
C57BL/6-Ly5.2 (wild type) were purchased from Charles River
(Saffron Walden, Essex, UK). C57BL/6w41/w41-Ly5.1 (W41)
were bred andmaintained at the University of Cambridge. Full de-
tails are available in the supplemental information.
Isolation of mouse Sca1high ESLAM HSCs, in vitro
assays, and expression profiling
HSCs were isolated from the lineage-depleted cell suspension by
using fluorescence-activated cell sorting using EPCRhigh, CD45+,
Sca-1high, CD48low/neg, andCD150+ (or ESLAM), as described previ-
ously (Kent et al., 2009) with full details found in the supplemental
information.
Bone marrow transplantation assays and analysis
Donor cells were obtained from C56BL/6J mice (CD45.2). Recip-
ient mice were C57Bl6W41/W41 (W41) mice as described previ-
ously (Benz et al., 2012; Kent et al., 2009).
Full details of transplantation and peripheral blood analysis are
in the supplemental information.
Lentiviral transduction of mouse HSCs
ESLAM HSCs (7,000 cells) were isolated and transduced with GFP-
containing lentivirus; full details of the transduction method and
assays are in the supplemental information.
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Isolation of human cord bloodHSCs and in vitro assays
Cord blood samples were obtained from the Cambridge Blood and
Stem Cell Biobank with informed consent from healthy donors in
accordance with regulated procedures approved by the relevant
Research and Ethics Committees. Details of HSC isolation and
in vitro assays are given in the supplemental information.
scRNA-seq
scRNA-seq analysiswas performed as described previously in Picelli
et al., 2014) (Smart-seq2), with full details given in the supple-
mental information. Data are publicly available using the GEO
accession number: GSE160131. All code is available upon request.
Xenotransplantation and analysis
Donor cells were obtained from CD34-enriched cord blood sam-
ples. Recipient mice were NSG. Full details of transplantation
and peripheral blood analysis are given in the supplemental
information.
SUPPLEMENTAL INFORMATION
Supplemental information can be found online at https://doi.org/
10.1016/j.stemcr.2021.04.002.
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